NALDI, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 4.997
EU - Europa 4.200
AS - Asia 1.571
AF - Africa 235
SA - Sud America 21
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.041
Nazione #
US - Stati Uniti d'America 4.956
GB - Regno Unito 1.049
IT - Italia 960
VN - Vietnam 546
SE - Svezia 526
CN - Cina 518
DE - Germania 505
IN - India 281
UA - Ucraina 247
FR - Francia 191
IE - Irlanda 173
RU - Federazione Russa 137
EE - Estonia 80
ZA - Sudafrica 79
CH - Svizzera 74
TG - Togo 63
BG - Bulgaria 57
CI - Costa d'Avorio 55
KR - Corea 37
IR - Iran 35
JO - Giordania 33
SG - Singapore 33
CA - Canada 31
BE - Belgio 30
FI - Finlandia 29
GR - Grecia 25
TR - Turchia 23
ES - Italia 20
SC - Seychelles 16
PT - Portogallo 15
HR - Croazia 14
NL - Olanda 13
HK - Hong Kong 11
AT - Austria 10
MX - Messico 10
NG - Nigeria 10
BR - Brasile 9
PL - Polonia 9
TH - Thailandia 9
TW - Taiwan 9
CL - Cile 8
DK - Danimarca 8
CZ - Repubblica Ceca 7
JP - Giappone 7
RO - Romania 7
EU - Europa 6
AU - Australia 5
ID - Indonesia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
LB - Libano 4
PK - Pakistan 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
EC - Ecuador 3
CM - Camerun 2
DZ - Algeria 2
IL - Israele 2
MA - Marocco 2
NO - Norvegia 2
PH - Filippine 2
SM - San Marino 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
EG - Egitto 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NC - Nuova Caledonia 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 11.041
Città #
Southend 948
Ashburn 757
Chandler 610
Fairfield 468
Dong Ket 374
Bologna 298
Wilmington 252
Houston 243
Princeton 230
Woodbridge 225
Seattle 189
Cambridge 181
Dublin 173
Ann Arbor 171
Jacksonville 165
Westminster 99
Berlin 89
Nanjing 81
Padova 79
Lomé 63
Milan 63
Medford 58
Bern 57
Sofia 56
Abidjan 55
Jinan 55
Shenyang 55
Turin 55
Hebei 46
Saint Petersburg 44
Redmond 42
San Diego 42
Falls Church 40
Beijing 38
New York 37
Redwood City 36
Boardman 34
Amman 33
Changsha 32
Brussels 29
Des Moines 29
Mülheim 29
Nanchang 27
Bremen 25
Dearborn 25
Singapore 21
Tianjin 21
Jiaxing 20
Helsinki 19
Paris 19
Mahé 16
Ottawa 16
Guangzhou 15
Hangzhou 15
Norwalk 14
Fremont 13
Verona 13
Haikou 12
Olalla 12
Rome 12
Taiyuan 11
Taizhou 11
Thessaloniki 11
Istanbul 10
Lappeenranta 10
Pune 10
Zhengzhou 10
Abeokuta 9
Amsterdam 9
Cesena 9
Chicago 9
Forlì 9
London 9
San Jose 9
San Venanzo 9
Florence 8
Frankfurt Am Main 8
Hong Kong 8
Lisbon 8
Los Angeles 8
New Haven 8
Ravenna 8
Washington 8
Costa Mesa 7
Kunming 7
Lausanne 7
Mountain View 7
Mumbai 7
Seoul 7
Toronto 7
Vienna 7
Chennai 6
Hyderabad 6
Lanzhou 6
Madrid 6
Nagold 6
Ardabil 5
Auckland 5
Bengaluru 5
Castel San Giorgio 5
Totale 7.290
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 459
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 222
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 213
Advanced analytical methodologies in Alzheimer's disease drug discovery 208
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 172
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 165
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 145
Antioxidant and cytoprotective effects of a wheat-derived non specific lipid transfer protein 2 (nsLTP2) on vascular endothelial cells 141
AFM study of F-actin on chemically modified surfaces 140
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 140
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 139
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 139
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 138
Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii 136
null 135
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 132
AFM study of F-actin on chemically modified surfaces 130
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 130
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 128
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 126
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 126
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 125
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 124
HS-SPME-GC-MS for the quantitation and chiral characterization of camphor and menthol in creams 123
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 120
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 120
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 120
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 117
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 117
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 112
Analytical approaches in Alzheimer’s disease Drug Discovery 111
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 110
New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy 109
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 109
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 108
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 107
Headspace solid-phase microextraction gas chromatography-mass spectrometry (HS SPME-GC-MS) determination of odorants in green tea 107
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3 107
Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen 106
Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2) 105
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 105
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 103
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 102
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 102
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 101
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 100
ANALYTICAL STRATEGIES FOR THE CHARACTERIZATION OF PROTEIN AGGREGATION AND INHIBITION IN HUMAN DISEASES 99
HEADSPACE SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY (HS SPME-GC-MS) DETERMINATION OF ODORANTS IN GREEN TEA 99
null 99
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 96
Immobilized enzyme-based analytical tools in the -omics era: recent advances 96
In vitro thrombogenicity of drug-eluting and bare metal stents 95
UHPLC determination of catechins for the quality control of green tea 94
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 93
null 92
Structural characterization of p53 isoforms due to the polymorphism at codon 72 by Mass Spectrometry and Circular Dichroism. 92
- Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 92
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 92
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis 91
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. 90
Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 89
Application of ESI-MS method for detailed characterization of GSK-3β inhibitors by monitoring GSM peptide phosphorylation.Angelini Farmaceutici. 88
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. 87
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING 85
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 85
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 83
Development of Beta-secretase monolithic micro-imer (immobilized enzyme reactor) for on-line HPLC studies 82
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 82
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 81
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 81
New Coumarin derivatives as cholinergic and cannabinoid system modulators 81
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 79
null 79
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 79
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 78
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 78
The role of Chromatography in Alzheimer’s Disease Drug Discovery. 78
Peptide mass mapping of acetylated isoforms of histone H4 from HT29 colon cancer cells 77
null 77
Hystones’ isoforms determined by HPLC-MS 76
HPLC determination of β-secretase activity on monolithic CIM disks 76
PROTEIN GLYCOSILATION ANALYSIS BY AN INTEGRATED PNGASE-F-IMER-LC-ESI-Q-TOF APPROACH 76
UHPLC ANALYSIS OF CATECHINS IN GREEN TEAS 75
Redox-sensitive structural features of transketolase from Chlamydomonas reinhardtii (CrTK) 74
EPITOPE IDENTIFICATION OF GLYCATED HSA AND THE EXTRACELLULAR REGION OF HUMAN RAGE BY SPR AND AFFINITY-MS SPECTROMETRY 73
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 73
null 72
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 71
Climate change effects on bread wheat phenology and grain quality: A case study in the north of Italy 70
Mass Spectrometry as efficient tool for the characterization of amyloid peptide 25-35 self-assembly species in aggregation and inhibition studies 69
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 69
Development of beta-secretase monolithic micro-IMER: characterization, activity and inhibition studies 68
GA‐RAGE – Effetti dell’albumina glicata plasmatica sulla stimolazione di RAGE nel diabete mellito di tipo 2 con complicanze renali 68
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 66
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. 64
Development of a new micro-patterned bio-sensing surface to screen for acetylcholinesterase PAS binders 60
Evidence of class I HDACs inhibition and cell cycle block in human carcinoma cells after (R) or (S)-9- HSA treatment 60
Self-assembly of biomolecules: AFM study of F-actin on unstructured and nanostructured surfaces 60
β-Amyloid-CORMs interaction monitoring by LC-ESI/MS and Circular Dichroism studies 60
PROTEOMIC ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF HUMAN HISTONES IN CANCER DRUG DISCOVERY 58
Totale 10.541
Categoria #
all - tutte 28.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.385 406 77 56 142 188 208 246 338 277 186 117 144
2020/20211.774 317 119 42 72 47 68 71 125 155 89 99 570
2021/20222.278 257 85 93 124 213 128 67 198 114 177 422 400
2022/20232.561 225 315 157 330 195 210 61 186 398 110 190 184
2023/20241.340 59 125 66 86 72 154 235 307 43 67 95 31
2024/202526 26 0 0 0 0 0 0 0 0 0 0 0
Totale 11.408